Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Deferred Taxes (2016 - 2025)

Harte Hanks (HHS) has disclosed Deferred Taxes for 15 consecutive years, with -$25000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Deferred Taxes rose 28.57% to -$25000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $899000.0, a 107.97% increase, with the full-year FY2024 number at -$9.3 million, down 529.51% from a year prior.
  • Deferred Taxes was -$25000.0 for Q3 2025 at Harte Hanks, down from -$15000.0 in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $975000.0 in Q4 2024 to a low of -$19.8 million in Q4 2022.
  • A 4-year average of -$2.6 million and a median of -$133500.0 in 2023 define the central range for Deferred Taxes.
  • Biggest YoY gain for Deferred Taxes was 195.49% in 2024; the steepest drop was 7084.29% in 2024.
  • Harte Hanks' Deferred Taxes stood at -$19.8 million in 2022, then skyrocketed by 94.85% to -$1.0 million in 2023, then surged by 195.49% to $975000.0 in 2024, then tumbled by 102.56% to -$25000.0 in 2025.
  • Per Business Quant, the three most recent readings for HHS's Deferred Taxes are -$25000.0 (Q3 2025), -$15000.0 (Q2 2025), and -$36000.0 (Q1 2025).